A regional project, struggling with cardiovascular diseases

Тип статьи:
Авторская



A regional project, struggling with cardiovascular diseases

A regional project, struggling with cardiovascular diseases


Madalas nagtatanong ang mga tao sa mga botika tungkol sa mga gamot laban sa presyon ng bagong henerasyon na walang side effects. Pero sa totoong buhay, hindi ito nangyayari. Lahat ng epektibong gamot ay may kanya-kanyang side effects. Kailangan mong maglaan ng maraming oras kasama ang iyong doktor para piliin ang tamang grupo ng gamot laban sa high blood pressure para sa'yo.

ЧИТАТЬ ДАЛЕЕ ...









































A regional project to combat cardiovascular disease: design, implementation, and first results Introduction Cardiovascular disease (CVD) is the leading cause of death and represent a significant burden for the health system. According to the data of the world health organization (WHO) are you for almost a third of all deaths. Particularly in rural regions of unfavorable Trends: often show a higher prevalence of risk factors such as Obesity, lack of exercise, Smoking, and unhealthy diet as well as less access to preventive health services. Against this Background, it was in the year 2023 in the Region of Mecklenburg‑Western Pomerania, the project «heart-healthy» life actively initiated. The objective of this project is to reduce the incidence and mortality of CVD in the target region through a combined strategy of prevention, awareness and early detection significantly. Objectives and methodology The primary objectives of the project include: Reduction in the prevalence of modifiable risk factors (hypertension, hyperlipidemia, Diabetes mellitus type 2, Obesity) to a minimum of 15% within three years. Increase participation in cardiac checkups to 25%. Improving the quality of life and health consciousness in people with existing CVD. To implement the following measures were implemented: Health screenings: free Regular blood pressure measurements, cholesterol and blood sugar tests in public facilities (community centres, sports clubs). Exercise programs: free Walking and Aqua-fitness‑groups for seniors, cooperation with local sports clubs to create a heart gymnastics classes. Nutritional counseling: an Interactive workshop on healthy eating and to the reduction of salt and sugar consumption, in particular for families with children. Awareness campaign: information materials (flyers, posters), lectures in companies and schools, as well as a targeted Online campaign on social media. Network structure: Close cooperation between family doctors, cardiologists, physiotherapists, health consultants to the creation of a coordinated care network. Implementation phase (until the 2023-2024) In the first year of the project focused on the design and pilot phase. There are 12 regional coordinators were trained, the taxes, the local measures. A total of more than 5000 people participated in the health screening. Of these, 18% unknown risk were found to be the factors (especially hypertension and hypercholesterolemia), which were subsequently treated by the in-house doctors. Participation in the exercise programs increased steadily and reached after six months, a stable value of an average of 200 students per week. The nutrition workshops were attended by 350 people, with a particularly high demand among parents of school children was observed. He first results and discussion The first results show a positive development: A reduction in mean blood pressure in the participants of 8-10 mmHg after half a year of regular participation in physical activity and nutrition programs. An increase in the participation in screening in the target population by 18% compared to the previous year. A significant improvement in health awareness, as measured by standardized questionnaires (rise of the middle, be aware of scores of 22%). This results in the effectiveness of a regional, community, swipe‑based prevention strategy. The close integration of medical care, physical activity and health-related education seems to be a synergy to achieve thematic effect. Conclusion and Outlook The project «heart-healthy» – that actively demonstrates that regional initiatives can make a significant contribution to the fight against cardiovascular diseases. The results obtained are promising and justify a continuation and possible scaling of the project to other regions. Further research is needed to evaluate the long-term effectiveness and cost-effectiveness of the measures.

With Cardio Balance supplement, you can enjoy the peace of mind that comes with taking control of your cardiovascular health. All the natural ingredients are expertly combined in the right dosages to support all your organs, ensuring they receive the necessary nutrients to function optimally. This all-natural solution helps regulate blood pressure and cholesterol levels without the fear of adverse side effects, empowering you to live your best life. A regional project, struggling with cardiovascular diseases. If you have disturbed sleep, fatigue, disorientation, confusion, or nervousness, it's time to monitor your blood pressure. Either lack of sleep or too much sleeping might mean your blood pressure is high or low. If it’s left untreated, you will soon face an onslaught of multiple illnesses.

Altai capsules for high blood pressure

The order of the cardiovascular diseases

Class of cardiovascular diseases

The treatment of cardiovascular diseases in pregnant women

https://devt.emodas.cy/articles/1873-cardiovascular-diseases-2020.html

https://shop.yagi.ru/articles/11072-disease-of-the-circulatory-system-examples.html

Ang Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay. Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.


Google
Google

Blood pressure tablets: Edarbi® High blood pressure (arterial hypertension) represents a worldwide health problem and is considered to be one of the main risk factors for cardiovascular disease, including heart attack, stroke and kidney failure. The effective reduction in blood pressure is, therefore, of crucial importance to reduce these risks. A modern medicines for the treatment of essential hypertension Edarbi®, the active substance of Azilsartan is Medoxomil is. This compound belongs to the class of Angiotensin II receptor antagonists (AT1‑receptor antagonists), which play a Central role in the Regulation of blood pressure. Mechanism of action Azilsartan Medoxomil acts receptors by selective and competitive Blockade of the AT1. Angiotensin II, a potent vasoconstrictor skills peptide in the Renin‑Angiotensin‑aldosterone‑System (RAAS), normally binds to these receptors, leads to: Vasoconstriction (Blood Vessel Narrowing), increased Aldosterone secretion, Fluid and Salt retention in the body. Due to the Blockade of AT1‑receptors Azilsartan prevented these effects, which leads to a Dilation of the blood vessels (vasodilation), and, ultimately, to a reduction in blood pressure. Clinical Efficacy Clinical studies have shown that Edarbi® provides an effective and long-lasting reduction in blood pressure. The effect starts about 2 weeks after the start of therapy and after 4-8 weeks, Maximum. The tablets are available in different dosages (20 mg, 40 mg and 80 mg), which is a customization of the therapy allows. Application and dosage The standard starting dose is 40 mg Edarbi® once a day. In case of insufficient blood pressure control, the dose can be increased to 80 mg. The tablet can be taken irrespective of meals to be made. In patients with moderate renal impairment no dose adjustment is required; in the case of severe renal or liver disease and in patients on dialysis Edarbi® is contraindicated, however, is contraindicated. Side effects Like any other medicine may cause Edarbi® side effects. The most common include: Dizziness, Headache, Fatigue, increased levels of Potassium in your blood (Hyperkalemia). In rare cases, more severe reactions may occur, such as functional disorders or allergic skin reactions kidneys. Conclusion Edarbi® (Azilsartan Medoxomil) is an effective therapeutic Option for patients with essential hypertension. Be targeted mechanism of action, and demonstrated blood pressure reduction in ability to support the recommendation for the application in long-term therapy. A careful Monitoring of patients, especially in the case of existing kidney or liver disease, however, is always required in order to minimize possible risks, and to ensure treatment safety.

Нет комментариев. Ваш будет первым!